GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (TSXV:MDCX) » Definitions » Cash And Cash Equivalents

Medicus Pharma (TSXV:MDCX) Cash And Cash Equivalents : C$7.19 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Cash And Cash Equivalents?

Medicus Pharma's quarterly cash and cash equivalents increased from Mar. 2024 (C$0.73 Mil) to Jun. 2024 (C$4.03 Mil) and increased from Jun. 2024 (C$4.03 Mil) to Sep. 2024 (C$7.19 Mil).

Medicus Pharma's annual cash and cash equivalents increased from Dec. 2021 (C$0.10 Mil) to Dec. 2022 (C$0.36 Mil) and increased from Dec. 2022 (C$0.36 Mil) to Dec. 2023 (C$2.31 Mil).

Medicus Pharma Cash And Cash Equivalents Historical Data

The historical data trend for Medicus Pharma's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Cash And Cash Equivalents Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
Cash And Cash Equivalents
0.10 0.36 2.31

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.91 2.31 0.73 4.03 7.19

Medicus Pharma Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Medicus Pharma  (TSXV:MDCX) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Medicus Pharma Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (TSXV:MDCX) » Definitions » Cash And Cash Equivalents
Comparable Companies
XCNQ:PSYG LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519 XTER:BAYN SHSE:600276 BIIB TSE:4503
Traded in Other Exchanges
MDCX:USA N460:Germany
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Website
https://www.medicuspharma.com
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.